GOOD SAMARITAN MEDICAL CTR — History
CCN 060116 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$314M
Latest Revenue (FY2022)
+0.3%
Revenue CAGR (3yr)
-1.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $312M | $329M | $314M | -4.4% | +0.3% |
| Operating Expenses | $299M | $284M | $317M | +11.7% | +3.0% |
| Operating Margin | 4.2% | 13.5% | -1.0% | -107.6% | +0.0% |
| Net Income | $13M | $45M | $-3M | -107.2% | +0.0% |
| Licensed Beds | 183 | 177 | 183 | +3.4% | +0.0% |
| Total Patient Days | 45,249 | 52,102 | 47,762 | -8.3% | +2.7% |
| Medicare Day % | 11% | 10% | 10% | +3.7% | -4.0% |
| Medicaid Day % | 14% | 12% | 14% | +13.2% | -0.9% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +0.6% ($312M → $314M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.3%
This Hospital
+7.6%
State Avg
Latest Margin
-1.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $315M | -3.6% |
| FY2024 (proj) | $316M | -6.2% |
| FY2025 (proj) | $317M | -8.8% |